T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$2.98B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.22B |
| 3 |
Elanco Animal Health
ELAN
|
+$1.15B |
| 4 |
Bank of America
BAC
|
+$840M |
| 5 |
Conagra Brands
CAG
|
+$718M |
Top Sells
| 1 |
Tesla
TSLA
|
+$2.03B |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$1.55B |
| 3 |
JPMorgan Chase
JPM
|
+$1.27B |
| 4 |
Booking.com
BKNG
|
+$1.04B |
| 5 |
Merck
MRK
|
+$804M |
Sector Composition
| 1 | Technology | 18.45% |
| 2 | Healthcare | 18.1% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Financials | 13.39% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Xencor
XNCR
$596M
| $195M | 0.03% |
6,283,547
-381,678
| -6% | -$11.9M |
|
477
ESCO Technologies
ESE
$5.3B
| $195M | 0.03% |
2,907,289
+35,604
| +1% | +$2.39M |
|
478
Okta
OKTA
$15.9B
| $194M | 0.03% |
2,348,452
-355,210
| -13% | -$29.4M |
|
|
WPX
479
DELISTED
WPX Energy, Inc.
WPX
| $194M | 0.03% |
14,791,091
+131,524
| +0.9% | +$1.72M |
|
480
Equitable Holdings
EQH
$15.8B
| $194M | 0.03% |
9,609,805
+998,778
| +12% | +$20.1M |
|
481
KeyCorp
KEY
$21.1B
| $193M | 0.03% |
12,231,224
-4,159,837
| -25% | -$65.5M |
|
482
Cardinal Health
CAH
$35.6B
| $192M | 0.03% |
3,988,003
+11,570
| +0.3% | +$557K |
|
483
Ally Financial
ALLY
$12.7B
| $192M | 0.03% |
6,971,147
+321,090
| +5% | +$8.83M |
|
|
GBT
484
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $191M | 0.03% |
3,604,134
+461,588
| +15% | +$24.4M |
|
485
Agios Pharmaceuticals
AGIO
$2.07B
| $189M | 0.03% |
2,801,812
+449,082
| +19% | +$30.3M |
|
486
Lattice Semiconductor
LSCC
$9.06B
| $188M | 0.03% |
15,764,863
-1,889,013
| -11% | -$22.5M |
|
487
Belden
BDC
$5.15B
| $188M | 0.03% |
3,497,875
+214,192
| +7% | +$11.5M |
|
488
Pediatrix Medical
MD
$1.44B
| $187M | 0.03% |
6,889,765
-1,911,086
| -22% | -$51.9M |
|
489
HDFC Bank
HDB
$180B
| $187M | 0.03% |
3,223,548
-415,880
| -11% | -$24.1M |
|
490
VeriSign
VRSN
$26.5B
| $183M | 0.03% |
1,007,133
-19,249
| -2% | -$3.49M |
|
491
Canadian Natural Resources
CNQ
$64.9B
| $182M | 0.03% |
13,530,678
-11,760,791
| -47% | -$158M |
|
492
Ralph Lauren
RL
$18.9B
| $182M | 0.03% |
1,402,405
-13,173
| -0.9% | -$1.71M |
|
493
Banco Bradesco
BBD
$33B
| $180M | 0.03% |
26,418,806
-513,180
| -2% | -$3.51M |
|
494
Carnival Corp
CCL
$42.5B
| $180M | 0.03% |
3,550,891
+8,236
| +0.2% | +$418K |
|
495
Sunstone Hotel Investors
SHO
$1.76B
| $178M | 0.03% |
12,341,977
-1,020,187
| -8% | -$14.7M |
|
496
RH
RH
$4.29B
| $178M | 0.03% |
1,724,448
-1,102,260
| -39% | -$113M |
|
497
Murphy Oil
MUR
$3.72B
| $177M | 0.03% |
6,041,689
+873,225
| +17% | +$25.6M |
|
|
PGRE
498
Paramount Group
PGRE
$1.6B
| $177M | 0.03% |
12,444,424
-906,174
| -7% | -$12.9M |
|
499
Macerich
MAC
$4.53B
| $176M | 0.03% |
4,071,461
-285,242
| -7% | -$12.4M |
|
|
MYOK
500
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $176M | 0.03% |
3,384,215
+901,783
| +36% | +$46.9M |
|